medigraphic.com

2017, Number 2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (2)

Protocol for the care of acute myocardial infarction in emergency: Código infarto (The Infarction Code)

Borrayo-Sánchez G, Pérez-Rodríguez G, Martínez-Montañez OG, Almeida-Gutiérrez E, Ramírez-Arias E, Estrada-Gallegos j, Palacios-Jiménez NM, Rosas PM, Arizmendi UE, Arriaga DJ

Language: Spanish
References: 23
Page: 233-246
PDF size: 337.83 Kb.


ABSTRACT

Cardiovascular diseases are a major public health problem because of their they impact on more than 30% of all deaths worldwide. In our country and in the Instituto Mexicano del Seguro Social (IMSS) are also the leading cause of death and the main cause of lost of healthy life years due to disability or premature death. 50% of deaths are premature; most of them are due to acute myocardial infarct. However, the investment for cardiovascular health is poor and there are no comprehensive cares programs focused on the treatment of this diseases or the control of their risk factors.
To address this problem, the first institutional care program was developed, called “A todo corazón”, which aims to strengthen actions to promote healthy habits, prevention and care of cardiovascular diseases. The initial approach is to implement a protocol of care emergency services called “Código infarto”, which is intended to ensure the diagnosis and treatment of patients demanding emergency care for acute myocardial infarction and receive reperfusion treatment with primary angioplasty in the first 90 minutes, or fibrinolytic therapy in the first 30 minutes after the admission to the IMSS emergency services.


REFERENCES

  1. Organización Mundial de la Salud. World Health Statistics 2011. Ginebra, Suiza: OMS; 2011.

  2. Instituto Nacional de Estadística y Geografía. Epidemiología de la defunción poblacional. México: INEGI; 2013.

  3. Organización para la Cooperación y el Desarrollo Económicos (OCDE). OECD Health Statistics. París, Francia: OCDE; 2013.

  4. Organización para la Cooperación y el Desarrollo Económicos (OCDE). OECD Health Statistics. París, Francia: OCDE; 2015.

  5. Lupi-Herrera E. El Registro Nacional de los Síndromes Isquémicos Coronarios Agudos (Renasica). Arch Cardiol Mex. 2002;72(Supl 2):45-64.

  6. García-Castillo A, Jerjes-Sánchez C, Martínez- Bermúdez P, Azpiri-López JR, Autrey-Caballero A, Martínez-Sánchez C et al. Registro Mexicano de Síndromes Coronarios Agudos (RENASICA II). Arch Cardiol Mex. 2005;75(Supl 1):S6-S19.

  7. Borrayo-Sánchez G, Madrid-Miller A, Arriaga-Nava R, Ramos-Corrales MA, García-Aguilar J, Almeida- Gutiérrez E. Riesgo estratificado de los síndromes coronarios agudos. Resultados del primer RENASCA-IMSS. Rev Med Inst Mex Seguro Soc. 2010;48(3):259-64.

  8. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F et al. A validated prediction model for all forms of acute coronary syndrome. Estimating the risk of 6-month post discharge death in an international registry. JAMA. 2004;291:2727-33.

  9. Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305(16):1677-84.

  10. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977; 56(5):786-94.

  11. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003;361:13-20.

  12. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY Cristofini P et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Data from the CAPTIM randomized clinical trial. Circulation. 2003;108(23):2851-56.

  13. Antman EM. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Eng J Med. 2006:354;1477-88.

  14. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation. 2013;127:529-55.

  15. Kaifoszova Z, Kala P, Alexander T, Zhang Y, Huo Y, Snyders A et al. Stent for Life Initiative: leading example in building STEMI systems of care in emerging countries. EuroIntervention. 2014;10(Suppl T):T87-T95.

  16. Myocardial Ischaemia National Audit Project [MINAP]. How the NHS cares for patients with heart attack. Annual public report April 2011 to March 2012. London: National Institute for Cardiovascular Outcomes Research; 2010. Disponible en: http:// www.ucl.ac.uk/nicor/audits/minap/publicreports/ pdfs/2012minappublicreportv2

  17. Cordero A, Lopez-Palop R, Carrillo P, Frutos A, Miralles S, Gunturiz C et al. Changes in Acute Coronary Syndrome Treatment and Prognosis After Implementation of the Infarction Code in Hospital With a Cardiac Catheterization Unit. Rev Esp Cardiol. 2016;69(8):754-9.

  18. Instituto Mexicano del Seguro Social. Dirección de Prestaciones Médicas.Procedimiento para la atención médica del paciente en el servicio de Urgencias en las unidades médicas hospitalarias de segundo nivel de atención 2660- 003-045. Ciudad de México, México: IMSS; 2009.

  19. Instituto Mexicano del Seguro Social. Dirección de Prestaciones Médicas. Procedimiento para la atención médica en el Área de Primer Contacto en el Servicio de Admisión Continua o Urgencias en Unidades Médicas Hospitalarias de Tercer Nivel 24-30-003- 040. Ciudad de México, México: IMSS; 2009.

  20. The task force on the management of ST-segment elevation acute myocardial infarction of European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569-2619.

  21. Lincoff AM, Topol EJ. Ilusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation. 1993;88(3):1361-74.

  22. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779-88.

  23. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V et al. Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Rev Esp Cardiol. 2009;62(3):e1-e47.




2020     |     www.medigraphic.com